Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for HSIC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -13.00M
March 31, 2026 -95.00M
December 31, 2025 -145.00M
September 30, 2025 -58.00M
June 30, 2025 -102.00M
March 31, 2025 -172.00M
December 31, 2024 -58.00M
September 30, 2024 -135.00M
June 30, 2024 -326.00M
March 31, 2024 -166.00M
December 31, 2023 -327.00M
September 30, 2023 -474.00M
June 30, 2023 -306.00M
March 31, 2023 -47.00M
December 31, 2022 -70.00M
September 30, 2022 -166.00M
June 30, 2022 -41.00M
March 31, 2022 -37.00M
December 31, 2021 -208.16M
September 30, 2021 -187.04M
June 30, 2021 -119.00M
March 31, 2021 -223.24M
December 31, 2020 -25.67M
September 30, 2020 -8.849M
June 30, 2020 -15.85M
Date Value
March 31, 2020 -84.19M
December 31, 2019 267.11M
September 30, 2019 -51.86M
June 30, 2019 -38.04M
March 31, 2019 -552.44M
December 31, 2018 -48.00M
September 30, 2018 -71.79M
June 30, 2018 -64.20M
March 31, 2018 -296.60M
December 31, 2017 -28.76M
September 30, 2017 -153.14M
June 30, 2017 -156.80M
March 31, 2017 -38.77M
December 31, 2016 -158.05M
September 30, 2016 -75.08M
June 30, 2016 -52.31M
March 31, 2016 -103.71M
December 31, 2015 -130.10M
September 30, 2015 -105.88M
June 30, 2015 -75.64M
March 31, 2015 -30.52M
December 31, 2014 -83.08M
September 30, 2014 -169.06M
June 30, 2014 -119.00M
March 31, 2014 -250.89M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Cencora, Inc. -240.15M
Accendra Health, Inc. -31.24M
Fuse Medical, Inc. --
Cardinal Health, Inc. -284.00M
McKesson Corp. 1.024B